Apexomic is a discovery CRO providing expert data analytics for life science R&D.
Together we can build the knowledge-base of your business - supporting scientists with actionable research insights, and leaders with investment-ready data and science-led business decision-making.
Since 2012, the company has completed a diverse range of projects with international academic, pharma, biotech and FMCG clients. We can carry out a single one-off project, participate in longer strategic challenges, add extra capability or capacity to your in-house bioinformaticians, or act as an outsourced bioinformatics full solution provider.
gene & protein expression • determining mechanism of action • biomolecular modelling & simulation • impact of variation on protein structure & function • immunology & oncology • networks & functional pathways • identifying biomarkers & targets • searching, integrating & visualising biological data
Visit the website and get in touch.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Stevenage Bioscience Catalyst, Gunnels Wood Road,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- appliedexomics.com
- Keywords
- Biomarker & drug target discovery, Data integration & visualisation, Biologics development, Protein immunogenicity, Molecular modelling, Bioinformatics, Data Analysis, Computational Biology.
- HQ
- Stevenage, Herts
Apexomic Questions
Apexomic's website is appliedexomics.com
Apexomic's LinkedIn profile is https://uk.linkedin.com/company/apexomic
Apexomic has
4 employees.
View email and phone details for 4
employees at Apexomic.
Apexomic's industry is
Biotechnology Research
Apexomic's top competitors are
York Pharma,
Bioluminux Clinical Research,
Isoform Oncology,
Nrg Therapeutics,
Neobe Therapeutics,
Ossianix,
Vasodynamics Ltd,
Antikor Biopharma Ltd,
Autifony Therapeutics,
Tessellate Bio.
Apexomic's categories are Biotechnology Research
Apexomic's founding year is 2012
